Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Pahl

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Immunobiology|August 13, 2015
Tricking the balance: NK cells in anti-cancer immunityJens Pahl, Adelheid Cerwenka
Trends in Immunology|October 28, 2022
Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagersSheena Pinto, Jens Pahl, Arndt Schottelius, et al.
Cell Death & Disease|August 4, 2017
MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cellsChristian Breunig, Jens Pahl, Moritz Küblbeck, et al.
Oncoimmunology|September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescenceFelix Funck, Jens Pahl, Lenka Kyjacova, et al.
Oncoimmunology|January 18, 2026
NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cellsLukas Heger, Tomasz Kaszubowski, Lukas Amon, et al.
Mabs|July 30, 2021
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumorsSusanne Wingert, Uwe Reusch, Stefan Knackmuss, et al.
European Journal of Immunology|October 21, 2025
CD16A Shedding Regulates Innate Cell Engager-Induced Serial Killing by Natural Killer CellsChiara Zambarda, Karolin Guldevall, Christian Breunig, et al.
Oncoimmunology|May 24, 2021
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cellsTobias Gutting, Veronika Hauber, Jens Pahl, et al.
Nature Communications|August 21, 2025
The bispecific innate cell engager AFM28 eliminates CD123<sup>+</sup> leukemic stem and progenitor cells in AML and MDSNanni Schmitt, Jana-Julia Siegler, Alexandra Beck, et al.
Nature Communications|March 8, 2016
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respirationGeorg Gdynia, Sven W Sauer, Jürgen Kopitz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Immunobiology|August 13, 2015
Tricking the balance: NK cells in anti-cancer immunityJens Pahl, Adelheid Cerwenka
Trends in Immunology|October 28, 2022
Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagersSheena Pinto, Jens Pahl, Arndt Schottelius, et al.
Cell Death & Disease|August 4, 2017
MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cellsChristian Breunig, Jens Pahl, Moritz Küblbeck, et al.
Oncoimmunology|September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescenceFelix Funck, Jens Pahl, Lenka Kyjacova, et al.
Oncoimmunology|January 18, 2026
NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cellsLukas Heger, Tomasz Kaszubowski, Lukas Amon, et al.
Mabs|July 30, 2021
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumorsSusanne Wingert, Uwe Reusch, Stefan Knackmuss, et al.
European Journal of Immunology|October 21, 2025
CD16A Shedding Regulates Innate Cell Engager-Induced Serial Killing by Natural Killer CellsChiara Zambarda, Karolin Guldevall, Christian Breunig, et al.
Oncoimmunology|May 24, 2021
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cellsTobias Gutting, Veronika Hauber, Jens Pahl, et al.
Nature Communications|August 21, 2025
The bispecific innate cell engager AFM28 eliminates CD123<sup>+</sup> leukemic stem and progenitor cells in AML and MDSNanni Schmitt, Jana-Julia Siegler, Alexandra Beck, et al.
Nature Communications|March 8, 2016
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respirationGeorg Gdynia, Sven W Sauer, Jürgen Kopitz, et al.
Pageof 2